Tirzepatide

GLP-1 / GIP

Overview

A dual GLP-1 / GIP receptor agonist — the 'twincretin' that pairs two incretin pathways for metabolic and glycemic research.

Researched effects

Researched for significant weight and visceral-fat loss
Strong glycemic control and improved insulin sensitivity
Appetite regulation and slowed gastric emptying
Studied effects on lipid profiles and blood pressure

Buy 2 vials, get your 3rd 50% off

Add a strength to your cart

Ask a question on WhatsApp →

View third-party certificates of analysis →Reconstitution calculator →

For research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease. The information above is educational summary of published research, not medical advice or a claim of results.